Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis.
Abstract
Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis.
Treatment of HCC is complicated by the fact that the disease is often diagnosed at an advanced stage when it is no longer amenable to curative surgery, and current systemic chemotherapeutics are mostly inefficacious. Sirtuin 1 (SIRT1) is a class III histone deacetylase that is implicated in gene regulations and stress resistance. In this study, we found that SIRT1 is essential for the tumorigenesis of HCC. We showed that while SIRT1 was expressed at very low levels in normal livers, it was over- Together, our findings reveal a novel function for SIRT1 in telomere maintenance of HCC, and they rationalize the clinical exploration of SIRT1 inhibitors for HCC therapy.
Precis
Findings offer a preclinical proof of concept for the clinical exploration of SIRT1 inhibitors for liver cancer treatment.
Introduction
Hepatocellular carcinoma (HCC) is the fifth most common malignancy and the third leading cause of cancer death worldwide (1) . Epidemiological evidence suggests a number of environmental factors associated with the development of HCC, including viral hepatitis type B (HBV) and C (HCV) infections, dietary aflatoxin, the male gender, and chronic liver disease (1, 2) ; however, the molecular mechanisms of HCC pathogenesis remains elusive. Although the cancer can be eradicated by curative surgery, most HCC patients are diagnosed at advanced stages when it is no longer amenable to curative therapies. The prognosis is very poor for patients who have unresectable tumors, with the median survival of around 6 months (3). HCC is highly refractory to chemotherapy. Even with the most effective forms of therapy, such as treatment with the anthracycline-based drug, doxorubicin, the response rate has been low (<20%) (4) . Therefore there is an urgent need to understand HCC carcinogenesis at the molecular level, and to identify novel molecular targets for the development of more efficacious therapeutics.
Sirtuins are mammalian homologs of the yeast silent information regulator 2 (SIR2), which are histone deacetylases (HDAC) that utilizes NAD + as a cofactor for their functions (5) . The yeast SIR2 plays a critical role in the extension of life span by repressing genome instability through establishing the transcriptional silencing of the mating-type loci, the ribosomal DNA locus, and the telomeres (6) . In mammals, SIR2
is represented by seven homologs (SIRT1-7), of which SIRT1 is considered to be the human orthologue of SIR2 (7). SIRT1 is a key regulator of energy metabolism by regulating fuel utilization according to the energy status of the organism (8) . At the cellular level, SIRT1 deacetylates both histones and non-histone targets including p53, FOXOs, E2F1, and Ku70 (9), and participates in stress response, DNA repair, and apoptosis (7, 10) . The deacetylated form of these proteins enhances cell survival by directing the cell to growth arrest for undergoing DNA repair over apoptosis in response to DNA damage. In addition, recent studies showed that SIRT1 interacts with telomeric repeats (11) , and plays a role in telomeric maintenance (11, 12) and genomic stability (13) . Overexpression of SIRT1 attenuates telomeric shortening associated with aging and augments homologous recombination (11) .
The clinical relevance of SIRT1 expression in HCC has not been examined previously. In this study, we found that SIRT1 is over-expressed in a subset of HCC.
Materials and Methods

Plasmids and antibodies
Lentivirus plasmid vectors pLKO.1-puro, and pLKO. antibodies were from Santa Cruz Biotechnology; p27 (554228) antibody was from BD Biosciences. ȕ-ACTIN antibodies (A5316) and α-tubulin antibodies (T5168)
were from Sigma-Aldrich.
HCC specimens
Tumorous liver tissues and the corresponding adjacent non-tumoral liver tissues were collected from 40 patients who underwent curative surgery for HCC at The Prince of Wales Hospital, Hong Kong. For these patients, the surgery was conducted in the morning after eight hours of fasting. The patients were not subjected to any form of chemotherapy prior to the surgery. Informed consent was obtained from each patient recruited, and the study protocol conformed to the ethical guidelines of the 1975
Declaration of Helsinki and was approved by the Clinical Research Ethics Committee of the Chinese University of Hong Kong. For these patients, the surgery was conducted in the morning after eight hours of fasting. The patients were not subjected to neo-adjuvant chemotherapy prior to surgery. Total RNAs and proteins were extracted from these specimens.
Tissue microarrays and immunohistochemistry
The HCC tissue microarrays were generated from formalin-fixed, paraffin-embedded archive tissues of 150 paired HCC. The samples were collected at The Prince of Wales
Hospital from 1995 to 2002. Tissue slides were deparaffinized, followed by quenching of endogenous peroxidase activity by hydrogen peroxide. SIRT1 antibody was applied at a dilution of 1:400. Chromogen development was performed using the universal HRP multimer ultraview kit (Ventana Medical System). The scoring of SIRT1 was carried out by two independent pathologists according to the proportion of tumor cells with positive nuclear staining (negative, none; weak, <=10%; moderate, 10 to <=50%; strong, >50%). 10% fetal bovine serum, 10 μg/ml selenium, 10 μg/ml transferrin and 10 μg/ml insulin. All cells were authenticated by short tandem repeat profiling analysis.
Cell culture
Lentivirus production
Lentivirus expressing shSIRT1-1, shSIRT1-2, or shCont was produced in HEK-293FT cells using the corresponding pLKO.1-puro vector with the aid of packaging plasmids pLP1, pLP2, and pLP/VSVG from BLOCK-iT Lentiviral RNAi Expression System (Invitrogen). The viruses were concentrated using PEG-it™ virus precipitation solution (System Biosciences) and stored at -80 o C.
RNA extraction and real-time quantitative PCR (qPCR)
Total RNA preparation and cDNA synthesis were carried out as described (15) .
Quantitative PCR experiments were performed using the SYBR Green PCR core reagent kit (Applied Biosystems). Detailed information of the qPCR reaction and the primer used are listed in the Supplementary Information, S1.
Western blotting analysis
Protein lysates were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a nitrocellulose membrane, and 
Cell proliferation and BrdU assay
Cell proliferation in response to SIRT1-silencing was determined by trypan blue exclusion assay. DNA synthesis was determined by the bromodeoxyuridine (BrdU) assay according to manufacturer's instructions (Roche Diagnostics Basel, Switzerland). The result was expressed as a percentage of the maximum absorbance at 450 nm based on three independent experiments. The effect of doxorubicin treatment on cell proliferation was measured by the MTT assay as described previously (16) .
Colony formation assay and soft agar assay
The colony formation assay was carried out as described (17) . Crystal violet-stained colonies were scored and results from duplicate assays were expressed as the mean from four independent experiments. For the soft agar assay, the base layer of each well consisted of 1.5 ml solidified media containing DEME with 10% FBS and 0.5% low melting point agarose. The top agar layer consisted of 5,000 SK-Hep-1 cells suspended in DEME with 0.35% low melting point agarose. Cells were allowed to grow for 3 weeks and the number of total colonies was counted under a microscope.
Each assay was done in triplicate.
Analysis of cell cycle distribution and apoptosis
Cell cycle distribution and apoptosis were determined by fluorescence-activated cell sorting (FACS) analysis as described (18) . Flow cytometry was carried out using a FACSCalibur flow cytometer (BD Bioscience). Data acquisition and analysis were done with CellQuest (BD Bioscience).
Senescence-associated ȕ-galactosidase (SA-ȕ-gal) staining
SA-ȕ-gal staining of cells was performed according to the method of Dimeri et al.
(1995).
Quantification of telomere dysfunction induced foci (TIF)
TIF was monitored by TRF2-ȖH2AX co-localization using immunofluorescence (IF). It also inhibited anchorage-independent growth of the cells as determined by soft agar assays ( Figure 2D ). Concordantly, SIRT1 knockdown reduced DNA synthesis as measured by BrdU incorporation ( Figure 2E ). Cell cycle analysis showed that significant G1 arrest was observed in SK-Hep-1 and HepG2 cells, whereas G2 arrest was observed in PLC5 and Hep3B cells ( Figure 2F ). Taken together, these data suggest that while reduced levels of SIRT1 repressed cell proliferation in general, it has disparate effects on cell cycle distribution in different HCC cells.
An earlier study showed that inhibition of SIRT1 leads to senescence-like growth arrest in breast and lung cancer cells (19) . We also observed that gene silencing of SIRT1 in SK-Hep-1 and HepG2 (p53 wild-type) resulted in cells that were enlarged in size, flattened in shape, and highly positive for senescenceassociated β-galatosidase (SA-β-gal) staining, whereas negative staining was observed in Hep3B and PLC5 (p53 null or mutated) cells ( Figure 3A ). SIRT1 silencing was associated with increased acetylation of FOXO1 (Supplementary Figure   2) , a well-known SIRT1 substrate, suggesting that there is a concordant reduction of SIRT1 expression and activity. Cellular senescence in SK-Hep-1 and HepG2 cells was associated with enhanced p53 acetylation on lysine 382 and induction of p21 that are known for their role in senescence induction (20) . Enhanced p53 acetylation, but not p21 induction, was observed in PLC5 cells, consistent with its mutated p53 status. On the other hand, the expression of two other proteins implicated in senescence, namely p27 and p16, was not changed significantly upon SIRT1 knockdown ( Figure 3B ).
Increased propensity to apoptotic cell death was evidenced by the enhanced PARP 
cleavage in Hep3B and PLC5 cells, compared with HepG2 and SK-Hep-1 cells ( Figure 3C ). Collectively, these data suggest that SIRT1 knockdown is associated with G1 arrest and cell senescence in p53 wild-type HCC cells, but leads to G2 arrest and apoptosis in p53 mutated HCC cells.
The role of SIRT1 in telomeric maintenance
Telomeres are nucleoprotein structures that protect the ends of chromosomes.
Mammalian telomeres are protected from being recognized as sites of DNA damage by the shelterin complex, which is composed of TRF1, TRF2, POT1, TIN2, PTOP and RAP1 respectively (21) . Either critically shortened telomeres, or the inhibition of shelterin causes telomeric dysfunction that is characterized by the activation of DNA damage response and the formation of telomere dysfunction-induced foci (TIF), leading to cellular senescence (22, 23) . To determine whether the observed cellular senescence or cell death is associated with telomeric dysfunction, we evaluated the expression of telomerase (TERT), members of the shelterin complex, and other PTOP plays an essential organizing function in shelterin and protects telomeres from TIF via recruiting POT1 (24) . It also recruits TERT to the telomere and regulates its activity (25, 26) . Gene knockdown of PTOP results in the activation of DNA damage signaling pathway, leading to telomeric fusion detectable in metaphase spreads (24) . Consistent with these known functions of PTOP, we observed that SIRT1 silencing significantly induced the formation of TIF in SK-Hep-1 cells as evidenced by co-localization of phosphorylated H2AX (γ-H2AX) and TRF2 ( Figure   4E Collectively, these data suggested that telomeric dysfunction and genetic instability are the major contributing factors to cell growth suppression induced by SIRT1 reduction.
Correlation between SIRT1, TERT and PTOP expression in human HCC.
To determine the relevance of the above SIRT1-regulated pathways in human subjects, we probed for the expression of TERT and PTOP in HCC by Western blotting using the same 40 paired HCC that have been used ( Figure 1B) to determine SIRT1 expression. Overall, TERT was expressed at a higher levels in HCC compared to adjacent non-tumoral liver tissues, whereas PTOP was expressed at a comparable level in these tissues ( Figure 5A ). Correlative analysis further revealed a significant association between tumoral induction of TERT and SIRT1 (Spearman's rank = 0.40, P=0.01) ( Figure 5B ), whereas the association between tumoral induction of SIRT1 and PTOP was not apparent (Spearman's rank = 0.08, P=0.21) ( Figure 5C ). These data suggest that a SIRT1-TERT regulatory axis may exist in vivo. 
Discussion
The role of SIRT1 in tumorigenesis is controversial. Increased SIRT1 expression has been found to reduce tumor formation in a mouse model of colon tumor (27) , whereas SIRT1 mutant mice exhibited increased DNA instability and are more susceptible to tumor development (28) . Reduced levels of SIRT1 mRNA and proteins are observed in breast tumors compared to normal tissue (28) . Intriguingly, however, SIRT1 over-expression is found in acute myeloid leukemia (29) , prostate (30) , skin (31), gastric (32) and colorectal cancers (33) , suggesting a tumorigenic role.
Therefore, the function of SIRT1 may be tumor-type specific and may also depend on the stage of tumorigenesis being assessed.
With regard to HCC, Wang et al found that SIRT1 mRNA is expressed at a comparable level in both tumor and non-tumoral tissues, by analyzing pooled microarray data from HCC samples. They further concluded that SIRT1 protein expression is reduced in HCC based on the analysis of one paired HCC specimen (28) . In agreement with their results, our study confirmed that SIRT1 mRNA levels do not differ between HCC and non-tumoral tissues. However, by analyzing SIRT1 protein expression using our large collection of paired frozen HCC tissues and histological sections, we have convincingly demonstrated that SIRT1 protein was indeed over-expressed in a subset of HCC by a post-transcriptional mechanism. We have also demonstrated that SIRT1 expression is low in normal and pre-malignant livers, and its positivity is closely associated with poorly differentiated histology.
Furthermore, reduced levels of SIRT1 suppressed cell proliferation and anchorageindependent growth of HCC cells. Together our data support the notion that SIRT1 over-expression may play a role in HCC tumorigenesis.
Recent studies also suggested that inhibition of SIRT1 may have anti-cancer potential. RNAi-mediated silencing of SIRT1 genes resulted in growth arrest or apoptosis in some epithelial tumor cells (34) , and reactivated tumor suppressor genes (35) . The SIRT1 inhibitor, sirtinol, induced senescence-like growth arrest in tumor cells (19) , whereas another inhibitor, cambinol, induced apoptosis of Burkitt lymphoma cells and suppressed the growth of tumor xenografts in vivo (36) . Our study revealed that the knockdown of SIRT1 in HCC cells resulted in the apoptosis or the characteristic senescence-like growth arrest phenotype closely resembling that of breast and lung cells treated with sirtinol (19) , suggesting that reduced SIRT1 activity may perturb pathways essential for cell proliferation in these cancer cells. 
We further identified telomeric dysfunction as one of the major phenotypes of reduced SIRT1 levels in HCC tumor cells. Telomeres are shortened on every DNA replication cycle due to the requirement of short RNA to prime DNA synthesis by DNA polymerases (37) . Progressive telomere shortening is also found in chronic liver injury and liver cirrhosis (38) . Telomere shortening triggers the DNA damage response, leading to cell cycle arrest, senescence, or apoptosis (39) , and it also serves as a tumor suppressor mechanism to limit the proliferation of transformed cells.
Nevertheless, TERT is activated in most tumors including HCC to overcome the telomere barrier by adding back telomere repeats to chromosome ends (38) . Inhibition of TERT shortens telomeres and causes cancer cell death (40) . TERT antagonists also inhibit tumor growth in a xenograft animal model of HCC (41) .
Although TERT plays a pivotal role in tumorigenesis, and we have showed that the proliferation of SIRT1-depleted HCC cells was rescued by TERT expression, we believe that telomere phenotypes in SIRT1-depleted cells did not result from telomeric attrition. This is because telomere shortening is a gradual process that requires a substantial number of cell division cycles for its effect on cell growth to become apparent. Therefore, the acute cell growth suppression effect as a result of SIRT1 knockdown argues against telomere attrition as the major mechanism. Indeed, telomeric length did not differ significantly between the control and SIRT1-depleted cells, as measured at 7 days after lentiviral transduction (Supplementary figure 6) .
Instead, our evidence suggests that TERT may contribute to cell survival via telomereindependent mechanisms (42) (43), and therefore, reduced expression of TERT in SIRT1 knockdown cells suppresses cell proliferation that can be rescued by its reexpression. Apparently, the TIF and nuclear abnormalities observed in SIRT1 knockdown cells are more likely due to the depletion of PTOP, or both PTOP and POT1. PTOP binds to and recruits POT1 to the telomere which is essential for telomere protection. The PTOP-POT1 complex also recruits TERT and is essential for its activity (25) . Over-expression of telomere-binding proteins is also found in many 
